Beverly Wilshire Ltd. Announces Receipt of SGX Listing and Quotation Notice for Multiple Share Issuances

Key Points of the Announcement

• Beverly Wilshire Ltd. has received a Listing and Quotation Notice (LQN) from the Singapore Exchange (SGX-ST) on 13 November 2025 for the listing and quotation of several tranches of new shares.
• The share issuances are linked to multiple corporate actions, including a major acquisition, subscription agreements, and debt capitalisation.
• Shareholders approved the Proposed Acquisition at the Extraordinary General Meeting (EGM) held on 8 September 2025.

Details of the Share Issuances

The LQN covers the following proposed share issuances:

1. KL Wellness City (H) Sdn Bhd Consideration Shares:
   • 186,565,970 new shares at an issue price of S\$0.014 per share, along with Warrants B.
   • Issued as part payment for the acquisition of the second floor of Tower A, Nobel Healthcare Park in KL Wellness City.
2. Khoo Poh Chye Subscription Shares:
   • 20,000,000 new shares at S\$0.010 per share.
   • Issued pursuant to a Subscription Agreement signed on 25 August 2025.
3. Tan Chin Hong Subscription Shares:
   • 9,174,311 new shares at S\$0.0109 per share.
   • Issued pursuant to a Subscription Agreement signed on 24 September 2025.
4. Cheah Sin Hing Debt Capitalisation Shares:
   • 5,000,000 new shares at S\$0.0120 per share.
   • Shares issued as part of a debt capitalisation agreement dated 24 September 2025, in lieu of outstanding remuneration.
5. Mageswari Rajoo Subscription Shares:
   • 8,547,008 new shares at S\$0.0117 per share.
   • Issued pursuant to a Subscription Agreement signed on 30 September 2025.

Implications and Price-Sensitive Information for Shareholders

• The aggregate issuance of new shares will significantly increase the Company’s share capital and may have a dilutive effect for existing shareholders.
• The acquisition of the second floor of Nobel Healthcare Park represents a strategic expansion into healthcare real estate, which could potentially enhance the Group’s future earnings and asset base.
• The Subscription Agreements and Debt Capitalisation arrangements introduce new stakeholders to the Company, which may affect future strategic direction and voting control.
• The KLWC Consideration Shares include Warrants B, potentially leading to further dilution if exercised.
• The SGX-ST’s Listing and Quotation Notice is subject to compliance with listing requirements, and is not an endorsement of the merits of the share issuances or the Company.
• There is a requirement for the KPC, TCH, and Mageswari Subscription Shares to be placed out within seven market days from the date of the LQN, indicating imminent share placement activity.
• The Company explicitly cautions shareholders that there is no certainty or assurance as of the announcement date that the proposed transactions will be completed, or that terms will not change. This uncertainty may result in volatility in the Company’s share price.

Advice to Investors

Shareholders and potential investors are strongly advised to exercise caution when trading Beverly Wilshire Ltd. shares. The substantial increase in share capital, strategic property acquisition, and new shareholder involvement may materially affect share price and the Company’s future prospects. Investors should monitor further announcements closely and consult professional advisors if they have any doubts regarding their investment decisions.

Additional Information

This document has been reviewed by Evolve Capital Advisory Private Limited, the Company’s Sponsor. However, the SGX-ST has neither examined nor approved the contents, and assumes no responsibility for the statements or opinions made.

Disclaimer

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Readers should consult their financial advisors before making any investment decisions. Beverly Wilshire Ltd.’s proposed transactions are subject to regulatory approvals and may be amended or not completed. The information herein is based on public disclosures as of 14 November 2025, and may be subject to change.

View B Wilshire Ltd Historical chart here